TY  - GEN
AU  - Deyell,Rebecca J
AU  - Wu,Bing
AU  - Rassekh,S Rod
AU  - Tu,Dongsheng
AU  - Samson,Yvan
AU  - Fleming,Adam
AU  - Bouffet,Eric
AU  - Sun,Xiaoqun
AU  - Powers,Jean
AU  - Seymour,Lesley
AU  - Baruchel,Sylvain
AU  - Morgenstern,Daniel A
TI  - Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218
SN  - 1545-5017
PY  - 2019///1112
KW  - Adolescent
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Canada
KW  - Child
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Neoplasm Recurrence, Local
KW  - drug therapy
KW  - Neoplasms
KW  - Prognosis
KW  - Salvage Therapy
KW  - Sirolimus
KW  - administration & dosage
KW  - Survival Rate
KW  - Vinblastine
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/pbc.27540
ER  -